Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly): 0.0836 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0836 |
| June 30, 2024 | 0.0215 |
| December 31, 2023 | 0.1166 |
| September 30, 2023 | 0.0956 |
| June 30, 2023 | 0.0654 |
| December 31, 2022 | 0.0302 |
| September 30, 2022 | 0.0661 |
| June 30, 2022 | 0.1417 |
| June 30, 2021 | 0.241 |
| March 31, 2021 | 0.2291 |
| December 31, 2020 | 0.2265 |
| September 30, 2020 | 0.4561 |
| June 30, 2020 | 0.0551 |
| March 31, 2020 | 0.3006 |
| December 31, 2019 | 0.3211 |
| September 30, 2019 | 0.2219 |
| June 30, 2019 | 0.2808 |
| March 31, 2019 | 0.1931 |
| December 31, 2018 | 0.2054 |
| September 30, 2018 | 0.2558 |
| June 30, 2018 | 0.3104 |
| March 31, 2018 | 0.2578 |
| December 31, 2017 | 0.398 |
| September 30, 2017 | 0.2586 |
| June 30, 2017 | 0.2311 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.209 |
| December 31, 2016 | 0.2202 |
| September 30, 2016 | 0.2344 |
| June 30, 2016 | 0.226 |
| March 31, 2016 | 0.1986 |
| December 31, 2015 | 0.2079 |
| September 30, 2015 | 0.2223 |
| June 30, 2015 | 0.21 |
| March 31, 2015 | 0.2144 |
| December 31, 2014 | 0.2435 |
| September 30, 2014 | 0.2187 |
| June 30, 2014 | 0.2057 |
| March 31, 2014 | 0.2398 |
| December 31, 2013 | 0.1565 |
| September 30, 2013 | 0.1657 |
| June 30, 2013 | 0.1763 |
| March 31, 2013 | 0.1782 |
| December 31, 2012 | 0.1103 |
| September 30, 2012 | 0.1188 |
| June 30, 2012 | 0.122 |
| March 31, 2012 | 0.1311 |
| December 31, 2011 | 0.0132 |
| September 30, 2011 | 0.0538 |
| June 30, 2011 | -0.0412 |
| March 31, 2011 | 0.1042 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.0215
Minimum
Jun 2024
0.4561
Maximum
Sep 2020
0.1634
Average
0.1166
Median
Dec 2023
EPS Diluted (Quarterly) Benchmarks
| Cellectis SA | -0.23 |
| Adaptimmune Therapeutics PLC | 0.24 |
| Akari Therapeutics PLC | -0.8025 |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -0.56 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 56.85M |
| Revenue (Quarterly) | 1.972B |
| Total Expenses (Quarterly) | 1.621B |
| Enterprise Value | 8.218B |
| Gross Profit Margin (Quarterly) | 40.53% |
| Profit Margin (Quarterly) | 2.88% |
| Earnings Yield | 3.32% |
| Operating Earnings Yield | 17.54% |
| Normalized Earnings Yield | 3.643 |